GLP-1 Agonist “Don’ts”: What to Avoid on Ozempic®, Wegovy®, Mounjaro®/Zepbound®

GLP-1 Agonist “Don’ts”: What to Avoid on Ozempic®, Wegovy®, Mounjaro®/Zepbound®

Dr G
Published on: 14/01/2026

Patients taking semaglutide or tirzepatide want practical, clinician-guided “don’ts” to reduce side effects, stay safe, and improve results for weight loss or diabetes—especially around diet, exercise, hydration, dosing, and safe sourcing.

GLP1